Xilis Presents Data at ESMO 2021 Demonstrating Capabilities of MicroOrganoSphere™ Technology for Cancer Drug Screening
Micro-organospheres: An Automated Platform for Repid Drug Screening in Patient-Derived Breast Cancer Organoids